Transforming growth factor β1 +869T/C gene polymorphism and essential hypertension: A meta-analysis Involving 2708 participants in the Chinese population

Internal Medicine

Volumn 50, Issue 10, 2011, Pages 1089-1092

  Li, Yan Yan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Chinese; Gene polymorphism; Hypertension; Meta analysis; Transforming growth factor 1

Indexed keywords

ARTICLE; CHINESE; ESSENTIAL HYPERTENSION; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; TRANSFORMING GROWTH FACTOR BETA1 GENE;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERTENSION; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79957618433     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4967     Document Type: Article

References (14)

1. Lijnen PJ, Petrov VV, Fagard RH. Association between transforming growth factor-beta and hypertension. Am J Hypertens 16: 604-611, 2003.
2. Cochran WG. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 24: 295-313, 1968.
3. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 7: 177-188, 1986.
4. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748, 1959.
5. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. Br Med J 315: 629-634, 1997.
6. Yamada Y, Miyauchi A, Goto J, et al. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 13: 1569-1576, 1998.
7. Suthanthiran M, Li B, Song JO, et al. Transforming growth factorbeta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci USA 97: 3479-3484, 2000.
8. Dunning AM, Ellis PD, McBride S, et al. A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 63: 2610-2615, 2003.
9. Yamada Y, Fujisawa M, Ando F, Niino N, Tanaka M, Shimokata H. Association of a polymorphism of the transforming growth factor-f1 gene with blood pressure in Japanese individuals. J Human Genet 47: 243-248, 2002.
10. Hu BC, Chu SL, Wang JG, Wang GL, Gao PJ, Zhu DL. Single nucleotide polymorphisms of three candidate genes in essential hypertension. Zhonghua Nei Ke Za Zhi (Chin J Intern Med) 45: 281-284, 2006 (in Chinese).
11. He F, Zhao D, Deng F, et al. Association of TGF-beta 1 gene polymorphisms in exon1 and blood levels with essential hypertension. Blood Press 19: 225-233, 2010.
12. Tang RG, Wei YS, Huang ZH. Association of the transforming growth factor-g1 +869T/C gene polymorphism and essential hypertension. Chinese Journal of Clinical Laboratory Science 27: 270-271, 2009 (in Chinese).
13. Wei CL, Wu YJ, Qiu Q, Yang H. Study on the relationship between transforming growth factor t1 gene polymorphism and essential hypertension. Chinese Journal of Gerontology 27: 962-964, 2007.
14. Zhao D, Hu QH, Deng FM, et al. Association of the TGFB1 level with essential hypertension in Kazakh Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (Chinese Journal of Medical Genetics) 27: 463-468, 2010 (in Chinese).